227 related articles for article (PubMed ID: 19309471)
1. Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivity.
Hitziger T; Schmidt M; Schottstedt V; Hennig H; Schumann A; Ross S; Lu M; Seifried E; Roggendorf M
Transfusion; 2009 Jul; 49(7):1306-13. PubMed ID: 19309471
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure.
Bes M; Esteban JI; Casamitjana N; Piron M; Quer J; Cubero M; Puig L; Guardia J; Sauleda S
Transfusion; 2009 Jul; 49(7):1296-305. PubMed ID: 19222816
[TBL] [Abstract][Full Text] [Related]
3. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
[TBL] [Abstract][Full Text] [Related]
4. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
5. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors.
Melve GK; Myrmel H; Eide GE; Hervig T
Transfusion; 2009 Nov; 49(11):2359-65. PubMed ID: 19702654
[TBL] [Abstract][Full Text] [Related]
7. Detection of free hepatitis C virus core antigen by enzyme-linked immunosorbent assay is not suitable for screening of granulocyte colony-stimulating factor-mobilized hematopoietic progenitor donors.
Lozano ML; Candela MJ; Cano H; Zuazu I; Vicente V
Transfusion; 2004 Dec; 44(12):1755-61. PubMed ID: 15584991
[TBL] [Abstract][Full Text] [Related]
8. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis C virus antibody in the serum of blood donors].
Barna TK; Ozsvár Z; Szendrényi V; Gál G
Orv Hetil; 1996 Mar; 137(10):507-11. PubMed ID: 8713664
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of the detection of hepatitis C virus core antigen].
Lu YC; Jiang ZY; Kuang YL; Chen WS; Tan YZ; Li DR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):635-7. PubMed ID: 17618587
[TBL] [Abstract][Full Text] [Related]
11. Performance characteristics of a microsphere immunoassay using recombinant HCV proteins as a confirmatory assay for the detection of antibodies to the hepatitis C virus.
McHugh TM
Cytometry A; 2005 Oct; 67(2):97-103. PubMed ID: 16163691
[TBL] [Abstract][Full Text] [Related]
12. Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors.
Tobler LH; Stramer SL; Lee SR; Baggett D; Wright D; Hirschkorn D; Walsh I; Busch MP
Vox Sang; 2005 Nov; 89(4):201-7. PubMed ID: 16262752
[TBL] [Abstract][Full Text] [Related]
13. Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?
Godkin A; Ng WF; Gallagher K; Betts G; Thomas HC; Lechler RI
J Allergy Clin Immunol; 2008 May; 121(5):1277-1284.e3. PubMed ID: 18355912
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to a novel antigen in acute hepatitis C virus infections.
Tobler LH; Stramer SL; Chien DY; Lin S; Arcangel P; Phelps BH; Cooper SL; Busch MP
Vox Sang; 2007 Jan; 92(1):1-7. PubMed ID: 17181584
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous detection of anti-HCV antibody and HCV core antigen.
Ansaldi F; Icardi G
Methods Mol Biol; 2009; 510():15-23. PubMed ID: 19009250
[TBL] [Abstract][Full Text] [Related]
18. A highly sensitive and specific enzyme-linked immunosorbent assay of antibodies to hepatitis C virus.
Eroglu C; Yildiz E; Ozturk M; Pinarbasi E
Acta Virol; 2000 Feb; 44(1):29-33. PubMed ID: 10989689
[TBL] [Abstract][Full Text] [Related]
19. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H
Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
[TBL] [Abstract][Full Text] [Related]
20. Antigenic relevance of F protein in chronic hepatitis C virus infection.
Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G
Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
